Fox Run Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,782
Closed -$797K 918
2018
Q2
$797K Buy
+4,782
New +$768K 0.25% 91
2018
Q1
Sell
-7,261
Closed -$1.19M 1023
2017
Q4
$1.19M Buy
+7,261
New +$1.3M 0.35% 40
2016
Q4
Sell
-2,700
Closed -$622K 750
2016
Q3
$622K Sell
2,700
-900
-25% -$220K 0.37% 47
2016
Q2
$832K Buy
+3,600
New +$830K 0.4% 22

Other funds holding AGN

Fox Run Management's AGN Position: Q3 2018 in Review

Fox Run Management sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 4,782 shares — an estimated $797K sold.

Fox Run Management first reported a position in AGN in Q2 2016 and held it in 4 quarters. The position peaked at $1.19M in Q4 2017. 1,066 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Fox Run Management reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Fox Run Management sold 4,782 Allergan plc shares in Q3 2018, an estimated $797K.
  • Fox Run Management first reported a position in Allergan plc in Q2 2016 and held it in 4 quarters.
  • Fox Run Management's Allergan plc position peaked at $1.19M in Q4 2017.
  • 1,066 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Fox Run Management's 13F filing for Q3 2018, filed 5 Oct 2018.